| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 95.32 / 113.90 |
Spark Therapeutics, Inc. (ONCE)
0.00
NASDAQ
| Exchange | NASDAQ |
| Div & Yield | N.A. (N.A) |
Latest News
Roche Deal for Spark Therapeutics Shows Biotech M&A Spark Hasn't Died
Acquisition deals for biotech companies at the start of 2019 are giving the sector a nice boost; here are other names that could be merger candidates.
Blueprint Medicines and Bluebird Bio Soar on ASH Announcements -- Biotech Movers
Blueprint unveiled new data from its ongoing Phase 1 study of avapritinib in advanced systemic mastocytosis at the 59th American Society of Hematology Annual Meeting.
Spark Therapeutics Is Ready to Catch Fire
Look for higher highs from this biotech play.
Apple Sits Out Tech Rally; S&P 500 Enjoys Record 2015 Winning Streak
Apple (AAPL) shares bucked the upward trend in tech stocks after Citigroup analysts cut iPhone sales estimates on Monday.